Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)

Abstract

Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPN) comprise a heterogeneous group of chronic hematologic malignancies. The quality of life, morbidity, and mortality of patients with MPN are primarily affected by disease-related symptoms, thromboembolic and hemorrhagic complications, and progression to myelofibrosis and acute leukemia… (More)
DOI: 10.1007/s00277-016-2621-2

Topics

1 Figure or Table

Cite this paper

@article{Appelmann2016DiagnosisPA, title={Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)}, author={Iris Appelmann and Stephan Kreher and Stefani Parmentier and H. -H. Wolf and Guido Bisping and Martin M. J. Kirschner and Frauke Bergmann and Kristina Schilling and Tim Henrik Br{\"{u}mmendorf and Petro E. Petrides and Andreas Tiede and Axel C. Matzdorff and Martin Griesshammer and Hanno B Riess and Steffen Koschmieder}, journal={Annals of Hematology}, year={2016}, volume={95}, pages={707-718} }